Articles by Erin Slifka

The Duke and Duchess of Sussex have landed lucrative entertainment deals since leaving England, often drawing on content from their personal lives. The big unknown: whether audiences will pay attention when they aren’t spilling the tea on the royal family.

Adam Rosendorff testified about what he called pervasive and persistent errors in the company’s blood-testing technology and his efforts to stop the startup from using its machines on real patients.

CVS, Walgreens say people will self-identify as meeting qualifications for third shots.

The embattled Chinese conglomerate said the pair are suspected of committing crimes and have been detained, but its operations haven’t been affected.

Commerce Secretary Gina Raimondo said in an interview with The Wall Street Journal that she would seek to improve U.S.-China business ties, saying business is of mutual benefit at a time of increasing tensions between the two nations.

Global investors who own China Evergrande’s U.S. dollar bonds were in the dark about whether the property giant would make a key interest payment, a major test of the highly indebted developer’s ability to avoid a default.

The recommendations were largely in line with the Food and Drug Administration’s authorization but diverged on giving the extra shot to people whose use was FDA-authorized: adults who work or live in places that put them at high risk of getting infected or transmitting to others.

The deal under discussion is expected to be valued at more than $2.5 billion and would vastly expand IAC’s stable of online publications, according to people familiar with the matter.